Could Ergothioneine Aid in the Treatment of Coronavirus Patients?
Infection with SARS-CoV-2 causes the coronavirus infectious disease 2019 (COVID-19), a pandemic that has, at present, infected more than 11 million people globally. Some COVID-19 patients develop a severe and critical illness, spurred on by excessive inflammation that can lead to respiratory or mult...
Saved in:
Main Authors: | Irwin K. Cheah (Author), Barry Halliwell (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023) -
Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons
by: Damien Meng-Kiat Leow, et al.
Published: (2024) -
Low Plasma Ergothioneine Predicts Cognitive and Functional Decline in an Elderly Cohort Attending Memory Clinics
by: Liu-Yun Wu, et al.
Published: (2022) -
S-Methyl-L-Ergothioneine to L-Ergothioneine Ratio in Urine Is a Marker of Cystine Lithiasis in a Cystinuria Mouse Model
by: Miguel López de Heredia, et al.
Published: (2021) -
Hercynine, Ergothioneine and Redox State in Stallion's Seminal Plasma
by: Salvatore Sotgia, et al.
Published: (2020)